المؤلفون: Qitong Chen (8888924), Dengjie Ouyang (8888927), Munawar Anwar (8888930), Ning Xie (518364), Shouman Wang (3842485), Peizhi Fan (8888933), Liyuan Qian (8888936), Gannong Chen (495041), Enxiang Zhou (553814), Lei Guo (36221), Xiaowen Gu (8888939), Boni Ding (8888942), Xiaohong Yang (109367), Liping Liu (133092), Chao Deng (329151), Zhi Xiao (4436815), Jing Li (10611), Yunqi Wang (370687), Shan Zeng (3464564), Jinhui Hu (2801707), Wei Zhou (24328), Bo Qiu (743480), Zhongming Wang (128167), Jie Weng (708913), Mingwen Liu (8888945), Yi Li (1144), Tiegang Tang (8888948), Jianguo Wang (1400488), Hui Zhang (7197), Bin Dai (320307), Wuping Tang (8888951), Tao Wu (16763), Maoliang Xiao (8888954), Xiantao Li (683919), Hailong Liu (734291), Lai Li (8545119), Wenjun Yi (8888957), Quchang Ouyang (6210956)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, breast cancer, HER2, pyrotinib, tumor mutation burden, metastases

Relation: https://figshare.com/articles/figure/Image_1_Effectiveness_and_Safety_of_Pyrotinib_and_Association_of_Biomarker_With_Progression-Free_Survival_in_Patients_With_HER2-Positive_Metastatic_Breast_Cancer_A_Real-World_Multicentre_Analysis_TIF/14169557

الاتاحة: https://doi.org/10.3389/fonc.2020.00811.s001

المؤلفون: Qitong Chen (8888924), Dengjie Ouyang (8888927), Munawar Anwar (8888930), Ning Xie (518364), Shouman Wang (3842485), Peizhi Fan (8888933), Liyuan Qian (8888936), Gannong Chen (495041), Enxiang Zhou (553814), Lei Guo (36221), Xiaowen Gu (8888939), Boni Ding (8888942), Xiaohong Yang (109367), Liping Liu (133092), Chao Deng (329151), Zhi Xiao (4436815), Jing Li (10611), Yunqi Wang (370687), Shan Zeng (3464564), Jinhui Hu (2801707), Wei Zhou (24328), Bo Qiu (743480), Zhongming Wang (128167), Jie Weng (708913), Mingwen Liu (8888945), Yi Li (1144), Tiegang Tang (8888948), Jianguo Wang (1400488), Hui Zhang (7197), Bin Dai (320307), Wuping Tang (8888951), Tao Wu (16763), Maoliang Xiao (8888954), Xiantao Li (683919), Hailong Liu (734291), Lai Li (8545119), Wenjun Yi (8888957), Quchang Ouyang (6210956)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, breast cancer, HER2, pyrotinib, tumor mutation burden, metastases

Relation: https://figshare.com/articles/dataset/Table_1_Effectiveness_and_Safety_of_Pyrotinib_and_Association_of_Biomarker_With_Progression-Free_Survival_in_Patients_With_HER2-Positive_Metastatic_Breast_Cancer_A_Real-World_Multicentre_Analysis_xlsx/14169560

الاتاحة: https://doi.org/10.3389/fonc.2020.00811.s002

المؤلفون: Qitong Chen (8888924), Dengjie Ouyang (8888927), Munawar Anwar (8888930), Ning Xie (518364), Shouman Wang (3842485), Peizhi Fan (8888933), Liyuan Qian (8888936), Gannong Chen (495041), Enxiang Zhou (553814), Lei Guo (36221), Xiaowen Gu (8888939), Boni Ding (8888942), Xiaohong Yang (109367), Liping Liu (133092), Chao Deng (329151), Zhi Xiao (4436815), Jing Li (10611), Yunqi Wang (370687), Shan Zeng (3464564), Jinhui Hu (2801707), Wei Zhou (24328), Bo Qiu (743480), Zhongming Wang (128167), Jie Weng (708913), Mingwen Liu (8888945), Yi Li (1144), Tiegang Tang (8888948), Jianguo Wang (1400488), Hui Zhang (7197), Bin Dai (320307), Wuping Tang (8888951), Tao Wu (16763), Maoliang Xiao (8888954), Xiantao Li (683919), Hailong Liu (734291), Lai Li (8545119), Wenjun Yi (8888957), Quchang Ouyang (6210956)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, breast cancer, HER2, pyrotinib, tumor mutation burden, metastases

Relation: https://figshare.com/articles/dataset/Table_2_Effectiveness_and_Safety_of_Pyrotinib_and_Association_of_Biomarker_With_Progression-Free_Survival_in_Patients_With_HER2-Positive_Metastatic_Breast_Cancer_A_Real-World_Multicentre_Analysis_xlsx/14169563

الاتاحة: https://doi.org/10.3389/fonc.2020.00811.s003